Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB

• Główni autorzy: Pingping Liu (Autor), Yinan Jiang (Autor), Xiaojing Zheng (Autor), Baoyue Pan (Autor), Huiling Xiang (Autor), Min Zheng (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: The systemic immune-inflammation index (SII) has been identified as a predictor of chemotherapy efficacy for a variety of cancers, and we aimed to determine its ability to predict the response to chemotherapy and its long-term prognosis for patients with cervical squamous cell carcinoma...